These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9136962

  • 1. Successful treatment of chronic severe neutropenia with weekly recombinant granulocyte-colony stimulating factor.
    Fine KD, Byrd TD, Stone MJ.
    Br J Haematol; 1997 Apr; 97(1):175-8. PubMed ID: 9136962
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.
    Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P.
    Blood; 1993 May 15; 81(10):2496-502. PubMed ID: 8490166
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neutropenia related to valacyclovir and valganciclovir in 2 renal transplant patients and treatment with granulocyte colony stimulating factor: a case report.
    Keles M, Yildirim R, Uyanik A, Turkmen M, Bilen Y, Aydinli B, Cetinkaya R, Polat KY.
    Exp Clin Transplant; 2010 Jun 15; 8(2):181-3. PubMed ID: 20565377
    [Abstract] [Full Text] [Related]

  • 8. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
    Perrier L, Lefranc A, Pérol D, Quittet P, Schmidt-Tanguy A, Siani C, de Peretti C, Favier B, Biron P, Moreau P, Bay JO, Lissandre S, Jardin F, Espinouse D, Sebban C.
    Appl Health Econ Health Policy; 2013 Apr 15; 11(2):129-38. PubMed ID: 23435861
    [Abstract] [Full Text] [Related]

  • 9. Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group.
    Kuritzkes DR, Parenti D, Ward DJ, Rachlis A, Wong RJ, Mallon KP, Rich WJ, Jacobson MA.
    AIDS; 1998 Jan 01; 12(1):65-74. PubMed ID: 9456256
    [Abstract] [Full Text] [Related]

  • 10. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.
    Roberts RL, Szelc CM, Scates SM, Boyd MT, Soderstrom KM, Davis MW, Glaspy JA.
    Am J Dis Child; 1991 Jul 01; 145(7):808-12. PubMed ID: 1711773
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor.
    Cottle TE, Fier CJ, Donadieu J, Kinsey SE.
    Semin Hematol; 2002 Apr 01; 39(2):134-40. PubMed ID: 11957197
    [Abstract] [Full Text] [Related]

  • 13. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.
    Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I, McKendrick J, Toner G, Bradstock K, Lieschke M, Cruickshank S, Tomita DK, Hoffman EW, Fox RM, Morstyn G.
    Ann Intern Med; 1994 Oct 01; 121(7):492-501. PubMed ID: 7520676
    [Abstract] [Full Text] [Related]

  • 14. Effect of filgrastim (G-CSF) during chemotherapy and abdomino-pelvic radiation therapy in patients with ovarian carcinoma.
    Fyles AW, Manchul L, Levin W, Robertson JM, Sturgeon J, Tsuji D.
    Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):843-7. PubMed ID: 9652847
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK, He XH, Yang S, Wang HQ, Jiang ZF, Zhu YZ, Ke XY, Zhang Y, Liu YP, Zhang WJ, Wang Z, Shi QZ, Xie XD, Zhang HL, Wang JJ, Luo DY, Zheng QS, Sun RY.
    Zhonghua Yi Xue Za Zhi; 2006 Dec 26; 86(48):3414-9. PubMed ID: 17313855
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human granulocyte colony-stimulating factor therapy for cyclic neutropenia associated with common variable immunodeficiency.
    Tsuda M, Urakami T, Watanabe S, Shimizu H, Inana I, Kikkawa Y, Kitagawa T.
    Acta Paediatr Jpn; 1993 Apr 26; 35(2):124-6. PubMed ID: 7684881
    [Abstract] [Full Text] [Related]

  • 17. [Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia].
    Asano S, Hirashima K, Yoshida Y, Takaku F, Miyazaki T, Omine M, Furusawa S, Abe T, Mori M, Arimori S.
    Rinsho Ketsueki; 1990 Sep 26; 31(9):1456-62. PubMed ID: 1701008
    [Abstract] [Full Text] [Related]

  • 18. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in a heart transplant patient.
    Gordon MS, O'Donnell JA, Mohler ER, Cooper MA.
    J Heart Lung Transplant; 1993 Sep 26; 12(4):706-7. PubMed ID: 7690254
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients.
    Mitchell PL, Morland B, Stevens MC, Dick G, Easlea D, Meyer LC, Pinkerton CR.
    J Clin Oncol; 1997 Mar 26; 15(3):1163-70. PubMed ID: 9060560
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.